Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours (Q35653933)
Jump to navigation
Jump to search
scientific article published on 27 October 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours |
scientific article published on 27 October 2011 |
Statements
1 reference
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours (English)
1 reference
Y Pan
1 reference
R Xu
1 reference
M Peach
1 reference
C-P Huang
1 reference
D Branstetter
1 reference
W Novotny
1 reference
R S Herbst
1 reference
S G Eckhardt
1 reference
P M Holland
1 reference
27 October 2011
1 reference
1 reference
105
1 reference
12
1 reference
1830-1838
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference